Custom Fine Chemical Manufacturing

Custom Fine Chemical Manufacturing
Product Description

Our comprehensive portfolio of services, integrated manufacturing, and regulatory leadership differentiates us as a leading contract development and manufacturing partner. With a proven ability to deliver solutions to complex challenges, Grace’s FCMS supports the entire small molecule development cycle from the pre-GMP clinical stage through cGMP commercial manufacturing.

From process development through the scale-up of RSMs to complex APIs, we work closely with you to achieve your development goals using the most efficient methods possible.

  • R&D / Analytical Services 
  • Custom APIs 
  • RSMs & Intermediates 
  • Integrated Scale-Up 
In addition to the resources we dedicate to supporting your next breakthrough product, Grace’s FCMS maintains an ongoing program to develop new APIs for several therapeutic indications.

W. R. Grace & Co

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Specifications
  • Supplied from
    United States

W. R. Grace & Co

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

More Products from W. R. Grace & Co (4)

  • Purification and Formulation of Oily APIs and Omega-3s

    Product Purification and Formulation of Oily APIs and Omega-3s

    Grace resins and excipients improve purity and create better targeted and higher value formulations with enhanced bioavailability. Grace is solving purification and formulation issues in oily APIs and Omega-3s in high quality separation capabilities, customization, reliability and speed to market, and ...
  • Purification and Formulation of Cannabinoids (CBD)

    Product Purification and Formulation of Cannabinoids (CBD)

    Grace has developed and introduced a patented silica based carrier, SYLOID® XDP silica, to directly convert liquid ingredients such as CBD into solid dosage forms. Extracting and purifying CBD from the hemp plant is a multi-step process which focuses on removal of several undesirable impurities. Grace ...
  • Drug Delivery for Enhanced Bioavailability of BCS2 (Poorly Soluble) Compounds

    Product Drug Delivery for Enhanced Bioavailability of BCS2 (Poorly Soluble) Compounds

    Engineered to bring together advanced silica technologies with challenging active pharmaceutical ingredients (APIs) to effectively formulate a large class of poorly soluble but otherwise promising compounds, Grace’s SILSOL® silica-based drug delivery technology provides solutions for poorly soluble act...
  • Custom Bonding and Chromatography Resins for Small and Large Molecule Purification

    Product Custom Bonding and Chromatography Resins for Small and Large Molecule Purification

    A wide range of DAVISIL® silica gel grades are available from one kg to multi-ton quantities to meet your application, performance, and economic requirements. DAVISIL® silicas are used to purify nutraceuticals, antibiotics, vaccine adjuvants, oil-based APIs, organic synthesis products (including intermedia...

W. R. Grace & Co resources (3)

  • News Grace Completes Acquisition of Fine Chemistry Business

    June 01, 2021: W. R. Grace & Co. announced the completion of its acquisition of the Fine Chemistry Services business (“FCS”) of Albemarle Corporation (NYSE: ALB) for approximately $570 million, including $300 million paid in cash and $270 million funded through the issuance to Albemarle of non-participating preferred equity of a newly created Grace subsidiary.
  • Brochure Grace Pharmaceutical Solutions Brochure

    Learn more about Grace's unmatched quality and reproducibility of our fine chemicals, chromatography resins, formulation excipients, and active ingredient delivery technologies.
  • Video Impurity Identification and Control Strategy for API Development

    A critical component of API process development is achieving a full understanding of the impurity profile while establishing a control strategy. Impurities can be introduced into an API at many stages in the process including through raw materials, product reactions, workup degradation, and isolation conditions.

    The ability to identify the origin of the various impurities, understanding their fate, and ultimately how they are purged from the final API are areas in which Grace’s Fine Chemical Manufacturing Services (FCMS) team has extensive expertise. Join our Learning Lab at CPHI Frankfurt to understand how a regimented impurity control strategy guided by research best practices and extensive knowledge of regulatory expectations are critical in API development.


    Click here to register